# Cronos Group share price today (Cronos Group Inc., CRON)

> Cronos Group Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. CRON · Healthcare · Drug Manufacturers - Specialty & Generic · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/cron

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $3.38 (+34.7% in a year)
- P/E: 18.0× (lower than 77% of the last 1 year)
- Revenue (Jun 2026): $53.0 M (+58.4% on a year ago)
- Profit (Jun 2026): $35.7 M
- Operating margin: 15.4% (+28.9 points on a year ago)
- ROE: 0%, FY25

The main question: the share price moved +34.7% in a year while yearly earnings per share moved −122.9%. The difference came from the market paying a higher multiple. ## What is the Cronos Group share price today? Cronos Group Inc.'s share price was $3.38 at the close on 3 November 2026. That is 18.2% above its average price over the last 200 trading days. In the last 52 weeks it traded between $2 and $3, and at that close it was at the high of that range. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 16 weeks in a row. Over the last 1 year the share price moved +62% while the S&P 500 moved +21%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Cronos Group pay? Cronos Group Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Cronos Group on? Cronos Group is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Cronos Group profitable? Cronos Group Inc. earned $35.7 M of net profit in the Jun 2026 quarter. The full FY25 year was a loss of $2.9 M. That is 67.3% of the quarter's revenue. The same quarter a year earlier lost $38.5 M. 6 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was −$2.9 M (−107.3% on the year before). On average over the last four quarters, profit changed +96.3% and revenue +37.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Cronos Group make, and is it growing? Cronos Group Inc. reported $53.0 M of revenue in the Jun 2026 quarter, +58.4% on the same quarter a year earlier. That is the 6th quarter in a row with growth on the year before. Over 4 years it has grown 22.8% a year on average. The last full year, FY25, came in at $147 M. The last four reported quarters add to $179 M. FY25 revenue was $147 M, +24.6% on the year before. Recent pace: the last four quarters grew +37.9% on average, against 22.8% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +37.5%, against +36.0% a year over the last 8 quarters (stabilising). ## How much of every $100 of sales does Cronos Group keep? Cronos Group Inc.'s operating margin was 15.4% in the Jun 2026 quarter, 28.9 percentage points higher than the same quarter a year ago. Across 5 years it has been between −256.4% and −11.6%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +28.9 percentage points on the year while gross margin changed +10.1 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Cronos Group's profit turning into cash? Cronos Group Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 it brought in $25.9 M of operating cash against −$2.9 M of profit. After $25.7 M of spending on assets, $149 K was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Cronos Group's cash go? Cronos Group Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $40.6 M on assets over the last 3 years. Averaged over those years that is 9.2% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $40.6 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Cronos Group's P/E ratio, and how does it compare with its own history? Cronos Group Inc.'s P/E is 18.0×, near the low end of its own history: it has been lower only 23% of the time. Its usual P/E (the middle reading) is 26.5×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −122.9% while the price moved +34.7%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Cronos Group business getting better or worse? Cronos Group Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Cronos Group earn on its capital? Cronos Group Inc. earned a ROE of 0% in FY25. That is up from a low of −30% in FY21. Its return on capital used (ROIC) is 11.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −2.0% net margin and 0.12× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −2.0% net margin × 0.12× asset turnover × 1.05× leverage (assets divided by equity) ≈ −0.3% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −0.6% − 10.9% = −11.5 percentage points. The 10.9% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Cronos Group have too much debt? Cronos Group Inc. has total debt of $1.3 M against shareholder equity of $1.1 B as of Jun 2026, so its debt is 0.00× its equity, which is very little. Year by year, that ratio went from 0.01 in FY21 to 0.00 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Cronos Group shareholding pattern? 2.1% of Cronos Group Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Cronos Group from balance-sheet trouble? For Cronos Group Inc., the Z-score is 10.97. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 10.97 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Cronos Group rank in its industry? There is no score against its industry: Cronos Group Inc. is not among the largest members shown in this industry comparison for Drug Manufacturers - Specialty & Generic. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Cronos Group compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Cronos Group in size? Cronos Group is the 31st largest of 51 Drug Manufacturers - Specialty & Generic companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Phibro Animal Health Corporation, Eton Pharmaceuticals, Inc. and Pacira BioSciences, Inc. Just below it: Amphastar Pharmaceuticals, Inc., Harrow, Inc. and Esperion Therapeutics, Inc. ### Drug Manufacturers - Specialty & Generic companies close in size

1. [Phibro Animal Health Corporation](https://www.sectoralpha.in/us/stocks/pahc) $1.5 billion
2. [Eton Pharmaceuticals, Inc.](https://www.sectoralpha.in/us/stocks/eton) $1.5 billion
3. [Pacira BioSciences, Inc.](https://www.sectoralpha.in/us/stocks/pcrx) $1.5 billion
4. Cronos Group Inc. $1.3 billion
5. [Amphastar Pharmaceuticals, Inc.](https://www.sectoralpha.in/us/stocks/amph) $1.2 billion
6. [Harrow, Inc.](https://www.sectoralpha.in/us/stocks/hrow) $1.1 billion
7. [Esperion Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/espr) $819 million

[All 51 Drug Manufacturers - Specialty & Generic companies, largest first](https://www.sectoralpha.in/us/sectors/drug-manufacturers-specialty-generic#all-companies)

### Companies close in size in other industries

1. [BigBear.ai Holdings, Inc.](https://www.sectoralpha.in/us/stocks/bbai) $1.2 billion · Information Technology Services
2. [Securitize Corp.](https://www.sectoralpha.in/us/stocks/secz) $1.2 billion · Financial Data & Stock Exchanges
3. Cronos Group Inc. $1.2 billion
4. [Old Second Bancorp, Inc.](https://www.sectoralpha.in/us/stocks/osbc) $1.2 billion · Banks - Regional
5. [Uranium Royalty Corp.](https://www.sectoralpha.in/us/stocks/uroy) $1.2 billion · Uranium

## What else do people ask about Cronos Group? ### What were Cronos Group's latest quarterly results? Cronos Group Inc. reported revenue of $53.0 M and net profit of $35.7 M for the Jun 2026 quarter. Earnings per share were $0.09. The operating margin was 15.4%, 28.9 percentage points higher than a year earlier (as of 3 November 2026). ### What is Cronos Group's market cap? Cronos Group Inc.'s market capitalisation is $1.3 B at a stock price of $3.38. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Cronos Group performing? Cronos Group Inc.'s latest readings are below. Over the past 13 weeks it has done better than the S&P 500, for 16 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Cronos Group's stock price go up? This page does not forecast Cronos Group Inc.'s stock price. What it shows instead: the stock price is $3.38. Its P/E of 18.0× is higher than 23% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Cronos Group in its business cycle? Cronos Group Inc.'s FY25 operating margin was −11.6%, against a 5-year range of −256.4% to −11.6%: the middle of its own range, neither a peak nor a low. The latest quarter was 15.4%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Cronos Group story? The main question: the share price moved +34.7% in a year while yearly earnings per share moved −122.9%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Cronos Group a stock worth studying right now? What the numbers show: Cronos Group Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.